sulfamethoxazole and trimethoprim
Generic: sulfamethoxazole and trimethoprim
Labeler: pharmasource meds, llcDrug Facts
Product Profile
Brand Name
sulfamethoxazole and trimethoprim
Generic Name
sulfamethoxazole and trimethoprim
Labeler
pharmasource meds, llc
Dosage Form
TABLET
Routes
Active Ingredients
sulfamethoxazole 800 mg/1, trimethoprim 160 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
82982-044
Product ID
82982-044_198ccc85-82fd-0a2b-e063-6394a90a249f
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA090624
Marketing Start
2023-02-28
Marketing End
2027-11-30
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
82982044
Hyphenated Format
82982-044
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
sulfamethoxazole and trimethoprim (source: ndc)
Generic Name
sulfamethoxazole and trimethoprim (source: ndc)
Application Number
ANDA090624 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 800 mg/1
- 160 mg/1
Packaging
- 14 TABLET in 1 BOTTLE (82982-044-14)
- 20 TABLET in 1 BOTTLE (82982-044-20)
Packages (2)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "198ccc85-82fd-0a2b-e063-6394a90a249f", "openfda": {"nui": ["N0000175504", "M0020790", "N0000185504", "N0000175489", "N0000000191", "N0000187062", "N0000187061"], "upc": ["0382982044204", "0382982044143"], "unii": ["JE42381TNV", "AN164J8Y0X"], "rxcui": ["198335"], "spl_set_id": ["f564a029-4b20-301a-e053-2995a90adcc0"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_epc": ["Sulfonamide Antimicrobial [EPC]", "Dihydrofolate Reductase Inhibitor Antibacterial [EPC]"], "pharm_class_moa": ["Cytochrome P450 2C9 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "manufacturer_name": ["Pharmasource Meds, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "14 TABLET in 1 BOTTLE (82982-044-14)", "package_ndc": "82982-044-14", "marketing_end_date": "20271130", "marketing_start_date": "20230228"}, {"sample": false, "description": "20 TABLET in 1 BOTTLE (82982-044-20)", "package_ndc": "82982-044-20", "marketing_end_date": "20271031", "marketing_start_date": "20230228"}], "brand_name": "Sulfamethoxazole and Trimethoprim", "product_id": "82982-044_198ccc85-82fd-0a2b-e063-6394a90a249f", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitor Antibacterial [EPC]", "Dihydrofolate Reductase Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]", "Sulfonamide Antimicrobial [EPC]", "Sulfonamides [CS]"], "product_ndc": "82982-044", "generic_name": "Sulfamethoxazole and Trimethoprim", "labeler_name": "Pharmasource Meds, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Sulfamethoxazole and Trimethoprim", "active_ingredients": [{"name": "SULFAMETHOXAZOLE", "strength": "800 mg/1"}, {"name": "TRIMETHOPRIM", "strength": "160 mg/1"}], "application_number": "ANDA090624", "marketing_category": "ANDA", "marketing_end_date": "20271130", "marketing_start_date": "20230228"}